We are live on ! Find out more
WSA

Wall Street Associates Portfolio holdings

AUM $151M
1-Year Est. Return 30.3%
This Fund
S&P 500
This Quarter Est. Return
+12.91%
1 Year Est. Return
+30.3%
3 Year Est. Return
+94.41%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.06B
AUM Growth
+$2.09M
Cap. Flow
-$58.5M
Cap. Flow %
-5.52%
Top 10 Hldgs %
16.9%
Holding
379
New
57
Increased
31
Reduced
195
Closed
48

Top Buys

Rank Stock Value
1
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$7.65M
2
PGND
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
+$7.12M
3
SPWH icon
Sportsman's Warehouse
SPWH
+$7.09M
4
EVH icon
Evolent Health
EVH
+$6.82M
5
TACO
Del Taco Restaurants, Inc. Common Stock
TACO
+$5.2M

Top Sells

Rank Stock Value
1
ASPX
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
+$32.7M
2
CSII
Cardiovascular Systems, Inc.
CSII
+$13.3M
3
VRTU
Virtusa Corporation
VRTU
+$9.09M
4
RGEN icon
Repligen
RGEN
+$8.82M
5
LOCO icon
El Pollo Loco
LOCO
+$7.78M

Sector Composition

Rank Sector Weight
1 Healthcare 29.16%
2 Technology 23.34%
3 Consumer Discretionary 14.42%
4 Industrials 9.4%
5 Communication Services 4.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BREW
101
DELISTED
Craft Brew Alliance, Inc.
BREW
$3.64M 0.34%
329,000
– –
BBW icon
102
Build-A-Bear
BBW
$435M
$3.63M 0.34%
227,100
-54,000
-19% -$956K
OXFD
103
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$3.6M 0.34%
260,100
-9,000
-3% -$122K
MTLS
104
Materialise
MTLS
$391M
$3.38M 0.32%
371,600
-6,100
-2% -$47.3K
DTLK
105
DELISTED
Datalink Corp
DTLK
$3.37M 0.32%
376,890
-72,210
-16% -$740K
ARGS
106
DELISTED
Argos Therapeutics, Inc.
ARGS
$3.13M 0.29%
22,825
-420
-2% -$67.1K
BAS
107
DELISTED
Basis Energy Services, Inc.
BAS
$3.08M 0.29%
716
-35
-5% -$170K
ALPN
108
DELISTED
Alpine Immune Sciences Inc
ALPN
$2.92M 0.27%
+48,100
New +$2.87M
TECH icon
109
Bio-Techne
TECH
$11.2B
$2.9M 0.27%
117,668
+46,196
+65% +$1.15M
UCTT
110
Ultra Clean Holdings
UCTT
$3.76B
$2.88M 0.27%
462,700
-176,800
-28% -$1.14M
GTIM icon
111
Good Times Restaurants
GTIM
$15M
$2.88M 0.27%
+327,000
New +$2.86M
TCON
112
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$2.83M 0.27%
1,250
– –
NVDQ
113
DELISTED
Novadaq Technologies Inc.
NVDQ
$2.45M 0.23%
202,507
– –
CLVS
114
DELISTED
Clovis Oncology, Inc.
CLVS
$2.44M 0.23%
27,743
-5,801
-17% -$497K
TPLM
115
DELISTED
Triangle Petroleum Corporation
TPLM
$2.41M 0.23%
479,800
-8,000
-2% -$42.9K
XLRN
116
DELISTED
Acceleron Pharma
XLRN
$2.4M 0.23%
76,000
-3,000
-4% -$96.8K
AXAS
117
DELISTED
Abraxas Petroleum Corp
AXAS
$2.36M 0.22%
40,000
– –
NUWE icon
118
Nuwellis
NUWE
$594K
– –
0
– –
ANAC
119
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$2.29M 0.22%
29,532
-30,298
-51% -$1.99M
ABG icon
120
Asbury Automotive
ABG
$3.88B
$2.25M 0.21%
24,791
-4,500
-15% -$391K
MDSO
121
DELISTED
Medidata Solutions, Inc.
MDSO
$2.22M 0.21%
40,852
-22,328
-35% -$1.2M
DARE icon
122
Dare Bioscience
DARE
$19.9M
$2.19M 0.21%
3,958
– –
AMN icon
123
AMN Healthcare
AMN
$1.19B
$2.17M 0.2%
68,707
-41,522
-38% -$1.08M
AIN icon
124
Albany International
AIN
$1.74B
$2.15M 0.2%
54,051
-9,200
-15% -$369K
HQY icon
125
HealthEquity
HQY
$8.65B
$2.14M 0.2%
+66,838
New +$1.79M
3 4
5
6 7

Similar funds

CF
CenterStar Fund Chicago, Illinois $159M AUM 13.43% 1-Year Est. Return
VWM
Vector Wealth Management Minneapolis, Minnesota $142M AUM 10.42% 1-Year Est. Return
HH
H7 Holdings Charlottesville, Virginia $141M AUM
NSCP
Night Square Capital Partners New York $136M AUM
EEG
E.E. Geduld $178M AUM 29.34% 1-Year Est. Return
BC
Bocage Capital San Francisco, California $185M AUM 61.49% 1-Year Est. Return
WRHAM
W.R. Huff Asset Management Stuart, Florida $116M AUM 5.81% 1-Year Est. Return
SRP
Saddle Road Partners Omaha, Nebraska $197M AUM 13.19% 1-Year Est. Return

Wall Street Associates's Q2 2015 Portfolio in Review

As of Q2 2015, Wall Street Associates held 379 positions worth $1.06B, up 0.2% from $1.06B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Wall Street Associates withdrew a net $58.5M in Q2 2015, closing 48 positions and reducing 195 holdings. Its most notable exit was AUSPEX PHARMACEUTICALS INC COM STK (DE), an estimated $32.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Wall Street Associates opened a new position in iShares Russell 2000 Growth ETF worth $7.71M.

  • Wall Street Associates's largest Q2 2015 buy was iShares Russell 2000 Growth ETF: 49,900 shares worth $7.71M.
  • Wall Street Associates added most to Marcus & Millichap in Q2 2015, an estimated $3.39M increase.
  • Wall Street Associates's biggest Q2 2015 reduction was Repligen, cutting an estimated $8.82M.
  • Wall Street Associates fully exited AUSPEX PHARMACEUTICALS INC COM STK (DE) in Q2 2015, selling an estimated $32.7M.
  • Wall Street Associates's ten largest holdings make up 17% of its $1.06B portfolio in Q2 2015.
  • Wall Street Associates opened 57 new positions and closed 48 in Q2 2015.
  • Wall Street Associates's portfolio value rose 0.2% quarter-over-quarter to $1.06B.

Based on Wall Street Associates's 13F filing for Q2 2015, filed 13 Aug 2015.